The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors.

MLA

Sharma, Navesh K., et al. “The American Brachytherapy Society Consensus Statement for Permanent Implant Brachytherapy Using Yttrium-90 Microsphere Radioembolization for Liver Tumors.” Brachytherapy, vol. 21, no. 5, Sept. 2022, pp. 569–91. EBSCOhost, https://doi.org/10.1016/j.brachy.2022.04.004.

APA

Sharma, N. K., Kappadath, S. C., Chuong, M., Folkert, M., Gibbs, P., Jabbour, S. K., Jeyarajah, D. R., Kennedy, A., Liu, D., Meyer, J. E., Mikell, J., Patel, R. S., Yang, G., & Mourtada, F. (2022). The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors. Brachytherapy, 21(5), 569–591. https://doi.org/10.1016/j.brachy.2022.04.004

Chicago

Sharma, Navesh K, S Cheenu Kappadath, Michael Chuong, Michael Folkert, Peter Gibbs, Salma K Jabbour, D Rohan Jeyarajah, et al. 2022. “The American Brachytherapy Society Consensus Statement for Permanent Implant Brachytherapy Using Yttrium-90 Microsphere Radioembolization for Liver Tumors.” Brachytherapy 21 (5): 569–91. doi:10.1016/j.brachy.2022.04.004.